{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:08:54Z","timestamp":1780693734933,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-025-06647-5","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:45:54Z","timestamp":1766141154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sarcopenia defined by serum creatinine and cystatin C predicts poor survival outcomes in patients with cancers"],"prefix":"10.1186","volume":"26","author":[{"given":"Rongqiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"3","key":"6647_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"6647_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends\u2013an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16\u201327.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"6647_CR3","first-page":"115","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"5 Suppl","key":"6647_CR4","doi-asserted-by":"publisher","first-page":"990s","DOI":"10.1093\/jn\/127.5.990S","volume":"127","author":"IH Rosenberg","year":"1997","unstructured":"Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990s\u20131s.","journal-title":"J Nutr"},{"issue":"4","key":"6647_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ageing\/afz046","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601.","journal-title":"Age Ageing"},{"issue":"3","key":"6647_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1447-0594.2012.00851.x","volume":"12","author":"C Wang","year":"2012","unstructured":"Wang C, Bai L. Sarcopenia in the elderly: basic and clinical issues. Geriatr Gerontol Int. 2012;12(3):388\u201396.","journal-title":"Geriatr Gerontol Int"},{"key":"6647_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101964","volume":"88","author":"D Geng","year":"2023","unstructured":"Geng D, Wu X, Wang Y, He J, Hu X. Sarcopenia defined by the psoas muscle mass or quality is associated with poor survival in patients with aortic aneurysm undergoing surgery: a meta-analysis. Ageing Res Rev. 2023;88:101964.","journal-title":"Ageing Res Rev"},{"issue":"12","key":"6647_CR8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/17474124.2018.1534586","volume":"12","author":"CS Hsu","year":"2018","unstructured":"Hsu CS, Kao JH. Sarcopenia and chronic liver diseases. Expert Rev Gastroenterol Hepatol. 2018;12(12):1229\u201344.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"6647_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcsm.13126","volume":"14","author":"P Fang","year":"2023","unstructured":"Fang P, Zhou J, Xiao X, Yang Y, Luan S, Liang Z, et al. The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14(1):3\u201316.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"Suppl 1","key":"6647_CR10","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.afos.2021.03.002","volume":"7","author":"PC Au","year":"2021","unstructured":"Au PC, Li HL, Lee GK, Li GH, Chan M, Cheung BM, et al. Sarcopenia and mortality in cancer: A meta-analysis. Osteoporos Sarcopenia. 2021;7(Suppl 1):S28-s33.","journal-title":"Osteoporos Sarcopenia"},{"issue":"4","key":"6647_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell. 2010;142(4):531\u201343.","journal-title":"Cell"},{"issue":"2","key":"6647_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"LK Chen","year":"2014","unstructured":"Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95\u2013101.","journal-title":"J Am Med Dir Assoc"},{"key":"6647_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.clnesp.2022.07.010","volume":"51","author":"C Tlemsani","year":"2022","unstructured":"Tlemsani C, Durand JP, Raynard B, Revel MP, Deluche E, Di Palma M, et al. Relationship between the creatinine\/cystatin C ratio and muscle mass measured by CT-scan in cancer patients. Clin Nutr ESPEN. 2022;51:412\u20138.","journal-title":"Clin Nutr ESPEN"},{"key":"6647_CR14","doi-asserted-by":"publisher","first-page":"897774","DOI":"10.3389\/fnut.2022.897774","volume":"9","author":"S Shi","year":"2022","unstructured":"Shi S, Jiang Y, Chen W, Chen K, Liao Y, Huang K. Diagnostic and prognostic value of the creatinine\/cystatin C ratio for low muscle mass evaluation among US adults. Front Nutr. 2022;9:897774.","journal-title":"Front Nutr"},{"issue":"3","key":"6647_CR15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4093\/dmj.2021.0074","volume":"46","author":"S Qiu","year":"2022","unstructured":"Qiu S, Cai X, Xie B, Yuan Y, Sun Z, Wu T. Normalized creatinine-to-cystatin C ratio and risk of diabetes in middle-aged and older adults: the China health and retirement longitudinal study. Diabetes Metab J. 2022;46(3):476\u201385.","journal-title":"Diabetes Metab J"},{"issue":"2","key":"6647_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.numecd.2023.09.004","volume":"34","author":"L Liao","year":"2024","unstructured":"Liao L, Shi S, Ding B, Zhang R, Tu J, Zhao Y, et al. The relationship between serum creatinine\/cystatin C ratio and mortality in hypertensive patients. Nutr Metab Cardiovasc Dis. 2024;34(2):369\u201376.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"6647_CR17","doi-asserted-by":"publisher","first-page":"996674","DOI":"10.3389\/fnut.2022.996674","volume":"26","author":"YY Hyun","year":"2022","unstructured":"Hyun YY, Lee KB, Kim H, Kim Y, Chung W, Park HC, et al. Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease. Front Nutr. 2022;26(9):996674.","journal-title":"Front Nutr"},{"key":"6647_CR18","doi-asserted-by":"publisher","first-page":"1155520","DOI":"10.3389\/fonc.2023.1155520","volume":"13","author":"S Gao","year":"2023","unstructured":"Gao S, Xie H, Wei L, Liu M, Liang Y, Wang Q, et al. Serum creatinine\/cystatin C ratio as a prognostic indicator for patients with colorectal cancer. Front Oncol. 2023;13:1155520.","journal-title":"Front Oncol"},{"key":"6647_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1364728","volume":"15","author":"H Ji","year":"2024","unstructured":"Ji H, Liu B, Jin P, Li Y, Cui L, Jin S, et al. Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer. Front Immunol. 2024;15:1364728.","journal-title":"Front Immunol"},{"issue":"4","key":"6647_CR20","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1002\/jcsm.13006","volume":"13","author":"CY Jung","year":"2022","unstructured":"Jung CY, Kim HW, Han SH, Yoo TH, Kang SW, Park JT. Creatinine-cystatin C ratio and mortality in cancer patients: a retrospective cohort study. J Cachexia Sarcopenia Muscle. 2022;13(4):2064\u201372.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"6647_CR21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.clnu.2023.03.023","volume":"42","author":"E Ashton","year":"2023","unstructured":"Ashton E, Arrondeau J, Jouinot A, Boudou-Rouquette P, Hirsch L, Huillard O, et al. Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors. Clin Nutr. 2023;42(6):944\u201353.","journal-title":"Clin Nutr"},{"issue":"1","key":"6647_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12877-022-02925-8","volume":"22","author":"C Zheng","year":"2022","unstructured":"Zheng C, Wang E, Li JS, Xie K, Luo C, Ge QY, et al. Serum creatinine\/cystatin c ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer. BMC Geriatr. 2022;22(1):207.","journal-title":"BMC Geriatr"},{"key":"6647_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1233768","volume":"14","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang J, Song G, Ding X, Sun H, Zhou J, et al. The coexistence of myosteatosis and the creatinine\/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery. Front Oncol. 2024;14:1233768.","journal-title":"Front Oncol"},{"issue":"7","key":"6647_CR24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s12603-021-1633-3","volume":"25","author":"X Chen","year":"2021","unstructured":"Chen X, Hou L, Shen Y, Wu X, Dong B, Hao Q. The role of baseline sarcopenia index in predicting chemotherapy-induced undesirable effects and mortality in older people with stage III or IV non-small cell lung cancer. J Nutr Health Aging. 2021;25(7):878\u201382.","journal-title":"J Nutr Health Aging"},{"key":"6647_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.","journal-title":"Trials"},{"issue":"9","key":"6647_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"6647_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193\u2013206.","journal-title":"Psychol Methods"},{"issue":"7109","key":"6647_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"2","key":"6647_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1017\/S1464793101005875","volume":"77","author":"MD Jennions","year":"2002","unstructured":"Jennions MD, M\u00f8ller AP. Publication bias in ecology and evolution: an empirical assessment using the \u201ctrim and fill\u201d method. Biol Rev Camb Philos Soc. 2002;77(2):211\u201322.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"5","key":"6647_CR30","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1245\/s10434-024-14969-8","volume":"31","author":"S Bi","year":"2024","unstructured":"Bi S, Jiang Y, Guan G, Sun X, Wang X, Zhang L, et al. Prognostic value of myosteatosis and creatinine-to-cystatin C ratio in patients with pancreatic cancer who underwent radical surgery. Ann Surg Oncol. 2024;31(5):2913\u201324.","journal-title":"Ann Surg Oncol"},{"key":"6647_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.963265","volume":"9","author":"P Ding","year":"2022","unstructured":"Ding P, Guo H, Sun C, Chen S, Yang P, Tian Y, et al. Serum creatinine\/cystatin c ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours. Front Nutr. 2022;9:963265.","journal-title":"Front Nutr"},{"issue":"6","key":"6647_CR32","volume":"32","author":"SX Jin","year":"2024","unstructured":"Jin SX, Liu BN, Ji HJ, Wu JR, Li BL, Gao XL, et al. Serum cytokines and creatinine\/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1\/PD-L1 therapy. Support Care Cancer. 2024;32(6):370.","journal-title":"Support Care Cancer"},{"issue":"1","key":"6647_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04628-z","volume":"21","author":"H Liu","year":"2023","unstructured":"Liu H, Wang J, Tan S, Zhang Z, Yan M, Han J, et al. Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker. J Transl Med. 2023;21(1):744.","journal-title":"J Transl Med"},{"issue":"12","key":"6647_CR34","doi-asserted-by":"publisher","first-page":"e1219","DOI":"10.1093\/oncolo\/oyad218","volume":"28","author":"BN Schmeusser","year":"2023","unstructured":"Schmeusser BN, Biermann H, Nicaise EH, Ali AA, Patil DH, Midenberg E, et al. Creatinine to cystatin-C ratio in renal cell carcinoma: a clinically pragmatic prognostic factor and sarcopenia biomarker. Oncologist. 2023;28(12):e1219\u201329.","journal-title":"Oncologist"},{"issue":"1","key":"6647_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02093-4","volume":"22","author":"J Sun","year":"2022","unstructured":"Sun J, Yang H, Cai W, Zheng J, Shen N, Yang X, et al. Serum creatinine\/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer. BMC Gastroenterol. 2022;22(1):26.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"6647_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3892\/ol.2024.14267","volume":"27","author":"Y Sun","year":"2024","unstructured":"Sun Y, Zhao J, Du J, Li Y, Ding F, Zhao W. Clinical implications and predictive value of the creatinine-cystatin C ratio in patients with multiple myeloma and renal impairment. Oncol Lett. 2024;27(3):134.","journal-title":"Oncol Lett"},{"issue":"3","key":"6647_CR37","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/jcsm.12977","volume":"13","author":"T Tang","year":"2022","unstructured":"Tang T, Xie L, Hu S, Tan L, Lei X, Luo X, et al. Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer. J Cachexia Sarcopenia Muscle. 2022;13(3):1800\u201310.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"6647_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/01635581.2023.2290299","volume":"76","author":"R Shodo","year":"2024","unstructured":"Shodo R, Yamazaki K, Ueki Y, Takahashi T, Yokoyama Y, Horii A. Sarcopenia index predicts short-term prognosis of head and neck squamous cell carcinoma. Nutr Cancer. 2024;76(2):149\u201359.","journal-title":"Nutr Cancer"},{"issue":"3","key":"6647_CR39","doi-asserted-by":"publisher","first-page":"102051","DOI":"10.1016\/j.clgc.2024.02.002","volume":"22","author":"S Yajima","year":"2024","unstructured":"Yajima S, Nakanishi Y, Ogasawara RA, Imasato N, Hirose K, Katsumura S, et al. Value of cystatin C-based sarcopenia index in patients undergoing surgery for renal tumors. Clin Genitourin Cancer. 2024;22(3):102051.","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"6647_CR40","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","volume":"30","author":"D Albano","year":"2020","unstructured":"Albano D, Messina C, Vitale J, Sconfienza LM. Imaging of sarcopenia: old evidence and new insights. Eur Radiol. 2020;30(4):2199\u2013208.","journal-title":"Eur Radiol"},{"key":"6647_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1058464","volume":"9","author":"WH Zheng","year":"2022","unstructured":"Zheng WH, Zhu YB, Yao Y, Huang HB. Serum creatinine\/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: a meta-analysis. Front Med (Lausanne). 2022;9:1058464.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"6647_CR42","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.clnu.2020.08.010","volume":"40","author":"K Hirai","year":"2021","unstructured":"Hirai K, Tanaka A, Homma T, Goto Y, Akimoto K, Uno T, et al. Serum creatinine\/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease. Clin Nutr. 2021;40(3):1274\u201380.","journal-title":"Clin Nutr"},{"issue":"2","key":"6647_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/jcsm.13175","volume":"14","author":"Y Jin","year":"2023","unstructured":"Jin Y, Ma X, Yang Z, Zhang N. Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14(2):697\u2013705.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"6647_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.dld.2015.03.010","volume":"47","author":"A Granito","year":"2015","unstructured":"Granito A, Marinelli S, Terzi E, Piscaglia F, Renzulli M, Venerandi L, et al. Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure. Dig Liver Dis. 2015;47(6):518\u201322.","journal-title":"Dig Liver Dis"},{"issue":"8","key":"6647_CR45","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/jpen.2415","volume":"46","author":"A Surov","year":"2022","unstructured":"Surov A, Wienke A. Prevalence of sarcopenia in patients with solid tumors: a meta-analysis based on 81,814 patients. JPEN J Parenter Enteral Nutr. 2022;46(8):1761\u20138.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"6647_CR46","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/SPC.0000000000000382","volume":"12","author":"F Pin","year":"2018","unstructured":"Pin F, Couch ME, Bonetto A. Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition. Curr Opin Support Palliat Care. 2018;12(4):420\u20136.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"18","key":"6647_CR47","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e146","volume":"37","author":"MR Cho","year":"2022","unstructured":"Cho MR, Lee S, Song SK. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction. J Korean Med Sci. 2022;37(18):e146.","journal-title":"J Korean Med Sci"},{"issue":"2","key":"6647_CR48","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-15-0533","volume":"229","author":"ME Cleasby","year":"2016","unstructured":"Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67-81.","journal-title":"J Endocrinol"},{"issue":"3","key":"6647_CR49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/gerona\/glp155","volume":"65","author":"E Zoico","year":"2010","unstructured":"Zoico E, Rossi A, Di Francesco V, Sepe A, Olioso D, Pizzini F, et al. Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level. J Gerontol A Biol Sci Med Sci. 2010;65(3):295\u20139.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"6647_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.trecan.2017.04.007","volume":"3","author":"A Ruiz-Casado","year":"2017","unstructured":"Ruiz-Casado A, Mart\u00edn-Ruiz A, P\u00e9rez LM, Provencio M, Fiuza-Luces C, Lucia A. Exercise and the hallmarks of cancer. Trends Cancer. 2017;3(6):423\u201341.","journal-title":"Trends Cancer"},{"issue":"1","key":"6647_CR51","first-page":"11","volume":"10","author":"A Pratesi","year":"2013","unstructured":"Pratesi A, Tarantini F, Di Bari M. Skeletal muscle: an endocrine organ. Clin Cases Miner Bone Metab. 2013;10(1):11\u20134.","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"3","key":"6647_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.ki.5002042","volume":"71","author":"CR Keller","year":"2007","unstructured":"Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int. 2007;71(3):239\u201344.","journal-title":"Kidney Int"},{"issue":"5","key":"6647_CR53","first-page":"5583","volume":"16","author":"WS Kwon","year":"2018","unstructured":"Kwon WS, Kim TS, Nahm CH, Moon Y, Kim JJ. Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden. Oncol Lett. 2018;16(5):5583\u201390.","journal-title":"Oncol Lett"},{"key":"6647_CR54","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.imlet.2018.01.006","volume":"196","author":"M Zi","year":"2018","unstructured":"Zi M, Xu Y. Involvement of cystatin C in immunity and apoptosis. Immunol Lett. 2018;196:80\u201390.","journal-title":"Immunol Lett"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06647-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06647-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06647-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T14:03:10Z","timestamp":1769176990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-025-06647-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6647"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06647-5","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"4 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}